Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma

Tohoku Journal of Experimental Medicine

Volumn 229, Issue 2, 2013, Pages 153-162

  Abdul Ghafar, Jamshid ^a   Soo Oh, Sung ^a   Park, Sun Mi ^a   Wairagu, Peninah ^a   Nyung Lee, Shun ^a   Jeong, Yangsik ^a   Eom, Minseob ^a   Yong, Suk Joong ^a   Jung, Soon Hee ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Adiponectin receptor; Immunohistochemistry; mRNA; Non small cell lung carcinoma; Polymerase chain reaction

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MESSENGER RNA;

ADIPONECTIN RECEPTOR 1 GENE; ADIPONECTIN RECEPTOR 2 GENE; ADULT; AGED; ARTICLE; BRONCHIOLITIS; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DOWN REGULATION; EMPHYSEMA; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; SMOKING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADIPONECTIN; REGRESSION ANALYSIS; REPUBLIC OF KOREA; SMOKING;

EID: 84876304521     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.229.153     Document Type: Article

References (41)

1. Abbasi, F., Farin, H.M., Lamendola, C., McLaughlin, T., Schwartz, E.A., Reaven, G.M. & Reaven, P.D. (2006) The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J. Clin. Endocrinol. Metab., 91, 5002-5007.
2. Barresi, V., Tuccari, G. & Barresi, G. (2009) Adiponectin immunohistochemical expression in colorectal cancer and its correlation with histological grade and tumour microvessel density. Pathology, 41, 533-538.
3. Benaitreau, D., Dieudonne, M.N., Dos Santos, E., Leneveu, M.C., Mazancourt, P. & Pecquery, R. (2009) Antiproliferative effects of adiponectin on human trophoblastic cell lines JEG-3 and BeWo. Biol. Reprod., 80, 1107-1114.
4. Blanquicett, C., Roman, J. & Hart, C.M. (2008) Thiazolidinediones as anti-cancer agents. Cancer Ther., 6, 25-34.
5. Bub, J.D., Miyazaki, T. & Iwamoto, Y. (2006) Adiponectin as a growth inhibitor in prostate cancer cells. Biochem. Biophys. Res. Commun., 340, 1158-1166.
6. Byeon, J.S., Jeong, J.Y., Kim, M.J., Lee, S.M., Nam, W.H., Myung, S.J., Kim, J.G., Yang, S.K., Kim, J.H. & Suh, D.J. (2010) Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int. J. Cancer, 127, 2758-2767.
7. Chandran, M., Phillips, S.A., Ciaraldi, T. & Henry, R.R. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care, 26, 2442-2450.
8. Chen, G., Gharib, T.G., Huang, C.C., Taylor, J.M., Misek, D.E., Kardia, S.L., Giordano, T.J., Iannettoni, M.D., Orringer, M.B., Hanash, S.M. & Beer, D.G. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics, 1, 304-313.
9. Cong, L., Gasser, J., Zhao, J., Yang, B., Li, F. & Zhao, A.Z. (2007) Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr. Relat. Cancer, 14, 713-720.
10. Cust, A.E., Kaaks, R., Friedenreich, C., Bonnet, F., Laville, M., Lukanova, A., Rinaldi, S., Dossus, L., Slimani, N., Lundin, E., Tjonneland, A., Olsen, A., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Joulin, V., Linseisen, J., Rohrmann, S., Pischon, T., Boeing, H., Trichopoulos, D., Trichopoulou, A., Benetou, V., Palli, D., Berrino, F., Tumino, R., Sacerdote, C., Mattiello, A., Quiros, J.R., Mendez, M.A., Sanchez, M.J., Larranaga, N., Tormo, M.J., Ardanaz, E., Bueno-de-Mesquita, H.B., Peeters, P.H., van, Gils, C.H., Khaw, K.T., Bingham, S., Allen, N., Key, T., Jenab, M. & Riboli, E. (2007) Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J. Clin. Endocrinol. Metab., 92, 255-263.
11. de Oliveira, C., de Mattos, A.B., Silva, C.B., Mota, J.F. & Zemdegs, J.C. (2012) Nutritional and hormonal modulation of adiponectin and its receptors adipoR1 and adipoR2. Vitam. Horm., 90, 57-94.
12. Dieudonne, M.N., Bussiere, M., Dos Santos, E., Leneveu, M.C., Giudicelli, Y. & Pecquery, R. (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun., 345, 271-279.
13. Dos Santos, E., Benaitreau, D., Dieudonne, M.N., Leneveu, M.C., Serazin, V., Giudicelli, Y. & Pecquery, R. (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol. Rep., 20, 971-977.
14. Gonullu, G., Kahraman, H., Bedir, A., Bektas, A. & Yucel, I. (2010) Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int. J. Colorectal. Dis., 25, 205-212.
15. Govindarajan, R., Ratnasinghe, L., Simmons, D.L., Siegel, E.R., Midathada, M.V., Kim, L., Kim, P.J., Owens, R.J. & Lang, N.P. (2007) Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J. Clin. Oncol., 25, 1476-1481.
16. Hamano, M., Kamada, Y., Kiso, S., Furuta, K., Kizu, T., Chatani, N., Egawa, M., Takemura, T., Ezaki, H., Yoshida, Y., Watabe, K., Hamasaki, T., Umeda, M., Furubayashi, A., Kinoshita, K., Kishida, O., Fujimoto, T., Yamada, A., Tsukamoto, Y., Tsutsui, S., Takehara, T., Hayashi, N. & Matsuzawa, Y. (2012) Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction: health check-up study of Japanese men. Hepatol. Res., (published online).
17. Ishikawa, M., Kitayama, J., Yamauchi, T., Kadowaki, T., Maki, T., Miyato, H., Yamashita, H. & Nagawa, H. (2007) Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors adipoR1 and adipoR2. Cancer Sci., 98, 1120-1127.
18. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C. & Thun, M.J. (2006) Cancer statistics, 2006. CA. Cancer J. Clin., 56, 106-130.
19. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. & Tobe, K. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 116, 1784-1792.
20. Kang, J.H., Lee, Y.Y., Yu, B.Y., Yang, B.S., Cho, K.H., Yoon, D.K. & Roh, Y.K. (2005) Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch. Pharm. Res., 28, 1263-1269.
21. Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Ohtsuka, N., Kusunoki, T. & Abe, M. (2010) Smoking status is associated with serum high molecular adiponectin levels in communitydwelling Japanese men. J. Atheroscler. Thromb., 17, 423-430.
22. Kelesidis, I., Kelesidis, T. & Mantzoros, C.S. (2006) Adiponectin and cancer: a systematic review. Br. J. Cancer, 94, 1221-1225.
23. Lee, J.G., Lee, C.Y., Bae, M.K., Park, I.K., Kim, D.J., Kim, K.D. & Chung, K.Y. (2008) Validity of international association for the study of lung cancer proposals for the revision of N descriptors in lung cancer. J. Thorac. Oncol., 3, 1421-1426.
24. Makita, S., Abiko, A., Nagai, M., Yonezawa, S., Koshiyama, M., Ohta, M. & Nakamura, M. (2012) Influence of daily alcohol consumption on serum adiponectin levels in men. Metabolism, (published online).
25. Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D.M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G. & Trichopoulos, D. (2004) Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab., 89, 1102-1107.
26. Michalakis, K., Williams, C.J., Mitsiades, N., Blakeman, J., Balafouta-Tselenis, S., Giannopoulos, A. & Mantzoros, C.S. (2007) Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol. Biomarkers Prev., 16, 308-313.
27. Miller, M., Cho, J.Y., Pham, A., Ramsdell, J. & Broide, D.H. (2009) Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J. Immunol., 182, 684-691.
28. Mistry, T., Digby, J.E., Chen, J., Desai, K.M. & Randeva, H.S. (2006) The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem. Biophys. Res. Commun., 348, 832-838.
29. Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y. & Noguchi, S. (2003) Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res., 9, 5699-5704.
30. Molica, S., Digiesi, G., Vacca, A., Mirabelli, R., Todoerti, K., Battaglia, C., Morabito, F., Neri, A. & Ribatti, D. (2009) Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia? Adv. Hematol., 2009, 287974.
31. Otsuka, F., Kojima, S., Maruyoshi, H., Matsuzawa, Y., Funahashi, T., Kaikita, K., Sugiyama, S., Kimura, K., Umemura, S. & Ogawa, H. (2009) Smoking cessation is associated with increased plasma adiponectin levels in men. J. Cardiol., 53, 219-225.
32. Petridou, E., Mantzoros, C., Dessypris, N., Koukoulomatis, P., Addy, C., Voulgaris, Z., Chrousos, G. & Trichopoulos, D. (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J. Clin. Endocrinol. Metab., 88, 993-997.
33. Petridou, E.T., Mitsiades, N., Gialamas, S., Angelopoulos, M., Skalkidou, A., Dessypris, N., Hsi, A., Lazaris, N., Polyzos, A., Syrigos, C., Brennan, A.M., Tseleni-Balafouta, S. & Mantzoros, C.S. (2007) Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology, 73, 261-269.
34. Sierksma, A., Patel, H., Ouchi, N., Kihara, S., Funahashi, T., Heine, R.J., Grobbee, D.E., Kluft, C. & Hendriks, H.F. (2004) Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care, 27, 184-189.
35. Spyridopoulos, T.N., Petridou, E.T., Skalkidou, A., Dessypris, N., Chrousos, G.P. & Mantzoros, C.S. (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int. J. Cancer, 120, 1573-1578.
36. Sull, J.W., Kim, H.J., Yun, J.E., Park, E.J., Kim, G. & Jee, S.H. (2009) Serum adiponectin is associated with smoking status in healthy Korean men. Endocr. J., 56, 73-78.
37. Takefuji, S., Yatsuya, H., Tamakoshi, K., Otsuka, R., Wada, K., Matsushita, K., Sugiura, K., Hotta, Y., Mitsuhashi, H., Oiso, Y. & Toyoshima, H. (2007) Smoking status and adiponectin in healthy Japanese men and women. Prev. Med., 45, 471-475.
38. Tworoger, S.S., Eliassen, A.H., Kelesidis, T., Colditz, G.A., Willett, W.C., Mantzoros, C.S. & Hankinson, S.E. (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J. Clin. Endocrinol. Metab., 92, 1510-1516.
39. Wei, E.K., Giovannucci, E., Fuchs, C.S., Willett, W.C. & Mantzoros, C.S. (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Natl. Cancer Inst., 97, 1688-1694.
40. Yoneda, K., Tomimoto, A., Endo, H., Iida, H., Sugiyama, M., Takahashi, H., Mawatari, H., Nozaki, Y., Fujita, K., Yoneda, M., Inamori, M., Nakajima, N., Wada, K., Nagashima, Y., Nakagama, H., Uozaki, H., Fukayama, M. & Nakajima, A. (2008) Expression of adiponectin receptors, adipoR1 and adipoR2, in normal colon epithelium and colon cancer tissue. Oncol. Rep., 20, 479-483.
41. Yoshizaki, T., Motomura, W., Tanno, S., Kumei, S., Yoshizaki, Y. & Okumura, T. (2010) Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells. J. Exp. Clin. Cancer Res., 29, 22.